Compound Summary
Compound Name: | 			NS 521 oxalate | 
Compound CID: | 			9907039 | 
Synonyms: | 			NS 521 oxalate 198969-52-7 1-(1-Butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine oxalate NS 521 3-(1-butylpiperidin-4-yl)-1H-benzimidazol-2-one;oxalic acid More... | 
Iupac Name: | 			3-(1-butylpiperidin-4-yl)-1H-benzimidazol-2-one;oxalic acid | 
InChI: | 					InChI=1S/C16H23N3O.C2H2O4/c1-2-3-10-18-11-8-13(9-12-18)19-15-7-5-4-6-14(15)17-16(19)20;3-1(4)2(5)6/h4-7,13H,2-3,8-12H2,1H3,(H,17,20);(H,3,4)(H,5,6) | 
InChIKey: | 				GMDFJIJNFIKGNV-UHFFFAOYSA-N | 
Canonical Smiles: | 		CCCCN1CCC(CC1)N2C3=CC=CC=C3NC2=O.C(=O)(C(=O)O)O | 
Isomeric Smiles: | 			CCCCN1CCC(CC1)N2C3=CC=CC=C3NC2=O.C(=O)(C(=O)O)O | 
Molecular Weight: | 		363.4 | 
Molecular Formula: | 			C18H25N3O5 | 
Molecular Weight: | 		363.4 | 
Molecular Formula: | 			C18H25N3O5 | 
Hydrogen Bond Donor Count: | 			3 | 
Hydrogen Bond Acceptor Count: | 			6 | 
Rotatable Bond Count: | 			5 | 
Heavy Atom Count: | 					26 | 
Complexity: | 				410 | 
| NS 521 oxalate | NS 521 oxalate | 
|---|---|
NS 521 oxalate | 			
198969-52-7 | 
1-(1-Butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine oxalate | 			
NS 521 | 
3-(1-butylpiperidin-4-yl)-1H-benzimidazol-2-one;oxalic acid | 			
EU-0100849 | 
MLS002153322 | 			
SCHEMBL5772154 | 
CHEMBL1257076 | 			
DTXSID60432681 | 
LP00849 | 			
NCGC00094177-01 | 
SMR001230735 | 			
N 7904 | 
SR-01000076031 | 			
SR-01000076031-1 | 
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 13.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | 13.000000000000000 | 1 | 1 |